TY - JOUR
KW - 3383:Drug & Alcohol Rehabilitation
KW - Adult
KW - Adulthood (18 yrs & older)
KW - Amines
KW - Analgesics, Opioid
KW - Anticonvulsants
KW - article
KW - Clinical Trial
KW - Cyclohexanecarboxylic Acids
KW - Detoxification
KW - Dose-Response Relationship, Drug
KW - Drug Rehabilitation
KW - Drug Therapy
KW - Drug Withdrawal
KW - Empirical Study
KW - Female
KW - gabapentin
KW - gabapentin dose
KW - gamma-Aminobutyric Acid
KW - Human
KW - Humans
KW - Interview
KW - Iran
KW - Male
KW - Mental Disorders
KW - Methadone
KW - Middle Age (40-64 yrs)
KW - Middle Aged
KW - Opiate Substitution Treatment
KW - opioid withdrawal
KW - opioid-related disorders
KW - Outpatient
KW - Quantitative Study
KW - Severity of Illness Index
KW - Substance Withdrawal Syndrome
KW - Thirties (30-39 yrs)
KW - Treatment Effectiveness Evaluation
KW - treatment efficacy
KW - Treatment Outcome
KW - Young Adult
KW - Young Adulthood (18-29 yrs)
AU - Mehrdad Salehi
AU - Gholam Reza Kheirabadi
AU - Mohammad Reza Maracy
AU - Mansour Ranjkesh
A1 - 
BT - Journal of clinical psychopharmacology
C5 - Opioids & Substance Use
CP - 5
IS - 5
JF - Journal of clinical psychopharmacology
PB - Lippincott Williams & Wilkins
PY - 2011
SN - 0271-0749, 0271-0749
SP - 293
EP - 596
EP - 
T1 - Importance of gabapentin dose in treatment of opioid withdrawal
T2 - Journal of clinical psychopharmacology
TI - Importance of gabapentin dose in treatment of opioid withdrawal
U1 - Opioids & Substance Use
UR - https://search.proquest.com/docview/909290305?accountid=28100
VL - 31
VO - 0271-0749, 0271-0749
Y1 - 2011
ER -